These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38554807)

  • 41. Residual risk of Pseudomonas aeruginosa waterborne contamination in an intensive care unit despite the presence of filters at all water points-of-use.
    Royer G; Virieux-Petit M; Aujoulat F; Hersent C; Baranovsky S; Hammer-Dedet F; Masnou A; Marchandin H; Corne P; Jumas-Bilak E; Romano-Bertrand S
    J Hosp Infect; 2024 Jul; 149():155-164. PubMed ID: 38705477
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Continued transmission of Pseudomonas aeruginosa from a wash hand basin tap in a critical care unit.
    Garvey MI; Bradley CW; Tracey J; Oppenheim B
    J Hosp Infect; 2016 Sep; 94(1):8-12. PubMed ID: 27249962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance.
    Fernández-Barat L; Ferrer M; De Rosa F; Gabarrús A; Esperatti M; Terraneo S; Rinaudo M; Li Bassi G; Torres A
    J Infect; 2017 Feb; 74(2):142-152. PubMed ID: 27865895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Establishment and multi drug resistance evolution of ST235 Pseudomonas aeruginosa strains in the intensive care unit of a Colombian hospital.
    Martinez E; Pérez JE; Buelvas F; Tovar C; Vanegas N; Stokes HW
    Res Microbiol; 2014 Dec; 165(10):852-6. PubMed ID: 25445011
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exogenous acquisition of Pseudomonas aeruginosa in intensive care units: a prospective multi-centre study (DYNAPYO study).
    Coppry M; Leroyer C; Saly M; Venier AG; Slekovec C; Bertrand X; Parer S; Alfandari S; Cambau E; Megarbane B; Lawrence C; Clair B; Lepape A; Cassier P; Trivier D; Boyer A; Boulestreau H; Asselineau J; Dubois V; Thiébaut R; Rogues AM
    J Hosp Infect; 2020 Jan; 104(1):40-45. PubMed ID: 31419468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Device-associated infections rates in adult, pediatric, and neonatal intensive care units of hospitals in the Philippines: International Nosocomial Infection Control Consortium (INICC) findings.
    Navoa-Ng JA; Berba R; Galapia YA; Rosenthal VD; Villanueva VD; Tolentino MC; Genuino GA; Consunji RJ; Mantaring JB
    Am J Infect Control; 2011 Sep; 39(7):548-54. PubMed ID: 21616564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiology and characterisation of carbapenem-non-susceptible Pseudomonas aeruginosa in a large intensive care unit in Jakarta, Indonesia.
    Saharman YR; Pelegrin AC; Karuniawati A; Sedono R; Aditianingsih D; Goessens WHF; Klaassen CHW; van Belkum A; Mirande C; Verbrugh HA; Severin JA
    Int J Antimicrob Agents; 2019 Nov; 54(5):655-660. PubMed ID: 31398483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pseudomonas aeruginosa outbreak in a pediatric intensive care unit linked to a humanitarian organization residential center.
    Longtin Y; Troillet N; Touveneau S; Boillat N; Rimensberger P; Dharan S; Gervaix A; Pittet D; Harbarth S
    Pediatr Infect Dis J; 2010 Mar; 29(3):233-7. PubMed ID: 19940801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tap out: reducing waterborne Pseudomonas aeruginosa transmission in an intensive care unit.
    Garvey MI; Wilkinson MAC; Holden KL; Martin T; Parkes J; Holden E
    J Hosp Infect; 2019 May; 102(1):75-81. PubMed ID: 30071267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pseudomonas aeruginosa device associated - healthcare associated infections and its multidrug resistance at intensive care unit of University Hospital: polish, 8.5-year, prospective, single-centre study.
    Litwin A; Rojek S; Gozdzik W; Duszynska W
    BMC Infect Dis; 2021 Feb; 21(1):180. PubMed ID: 33593280
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidemiology of Carbapenem-resistant Enterobacteriaceae in Egyptian intensive care units using National Healthcare-associated Infections Surveillance Data, 2011-2017.
    Kotb S; Lyman M; Ismail G; Abd El Fattah M; Girgis SA; Etman A; Hafez S; El-Kholy J; Zaki MES; Rashed HG; Khalil GM; Sayyouh O; Talaat M
    Antimicrob Resist Infect Control; 2020; 9(1):2. PubMed ID: 31911830
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence, Microbiological Profile and Risk Factors of Healthcare-Associated Infections in Intensive Care Units: A 10 Year Observation in a Provincial Hospital in Southern Poland.
    Kołpa M; Wałaszek M; Gniadek A; Wolak Z; Dobroś W
    Int J Environ Res Public Health; 2018 Jan; 15(1):. PubMed ID: 29324651
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A prospective multicentre surveillance study to investigate the risk associated with contaminated sinks in the intensive care unit.
    Valentin AS; Santos SD; Goube F; Gimenes R; Decalonne M; Mereghetti L; Daniau C; van der Mee-Marquet N;
    Clin Microbiol Infect; 2021 Sep; 27(9):1347.e9-1347.e14. PubMed ID: 33640576
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit.
    Kohlenberg A; Weitzel-Kage D; van der Linden P; Sohr D; Vögeler S; Kola A; Halle E; Rüden H; Weist K
    J Hosp Infect; 2010 Apr; 74(4):350-7. PubMed ID: 20170982
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
    Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
    Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased financial burdens and lengths of stay in patients with healthcare-associated infections due to multidrug-resistant bacteria in intensive care units: A propensity-matched case-control study.
    Su LH; Chen IL; Tang YF; Lee JS; Liu JW
    PLoS One; 2020; 15(5):e0233265. PubMed ID: 32421700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frequency and predictors of colonization of the respiratory tract by VIM-2-producing Pseudomonas aeruginosa in patients of a newly established intensive care unit.
    Horianopoulou M; Legakis NJ; Kanellopoulou M; Lambropoulos S; Tsakris A; Falagas ME
    J Med Microbiol; 2006 Oct; 55(Pt 10):1435-1439. PubMed ID: 17005794
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study.
    Yang SP; Chen YY; Hsu HS; Wang FD; Chen LY; Fung CP
    BMC Infect Dis; 2013 Jan; 13():10. PubMed ID: 23298156
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients.
    Peña C; Guzmán A; Suarez C; Dominguez MA; Tubau F; Pujol M; Gudiol F; Ariza J
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1967-71. PubMed ID: 17420207
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients.
    Tumbarello M; De Pascale G; Trecarichi EM; Spanu T; Antonicelli F; Maviglia R; Pennisi MA; Bello G; Antonelli M
    Intensive Care Med; 2013 Apr; 39(4):682-92. PubMed ID: 23370828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.